Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2013 Feb 4;190(6):2631–2640. doi: 10.4049/jimmunol.1201897

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2013 by The American Association of Immunologists, Inc.

This article is distributed under The American Association of Immunologists, Inc., Reuse Terms and Conditions for Author Choice articles.

PMC Copyright notice

FIGURE 7. — Administration of IFN-β does not affect the accumulation of MDSCs in the periphery of MOG/CFA immunized mice. (A and B) MOG/CFA immunized mice treated daily with 2 μg rIFN-β (Rebif) from days 0–5. At day 6, mice sacrificed and analyzed by flow cytometry for the frequency of MDSCs in the periphery. (A) Frequency and (B) absolute numbers of MDSCs in the spleen of control or IFN-β–treated mice. Data are representative of two independent experiments. Each mouse was analyzed individually (n = 5/group). ns, Nonsignificant.